Close Menu
Home › Bio-Techne, Lisen Partner on MDx Products for Chinese Market

Bio-Techne, Lisen Partner on MDx Products for Chinese Market

Feb 26, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Bio-Techne today announced a strategic agreement with China's Lisen Imprinting Diagnostics Wuxi in the field of precision medicine.

Specifically, the partnership, Minneapolis-based Bio-Techne said, will accelerate the development of molecular diagnostics in the Chinese market. Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

What's Popular?

In Molecular Diagnostics

  1. Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

    Premium

  2. QuantuMDx Raises $14M to Support Development of POC Genotyping Assay

  3. Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers

    Premium

  4. Noscendo, University Hospital Bonn Partner on Pathogen-Detection Platform Development

  5. Co-Diagnostics Selling $5M of Shares

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.